CD 19 COUNT

The CD19 count is pivotal in Hypro Diagnostics, indicating the presence of CD19-positive cells within a sample. This measurement holds immense significance in diagnosing and monitoring conditions, especially hematological malignancies like B-cell lymphomas and leukemias. It plays a crucial role in evaluating the efficacy of targeted therapies, specifically those designed to address CD19-positive cells. Tracking fluctuations in CD19 counts assists in gauging disease advancement and the body’s reaction to treatments, aiding greatly in tailoring personalized care approaches for patients.